연구동향 분석

Efficacy and Safety of Ghrelin Agonists in Patients with Diabetic Gastroparesis: A Systematic Review and Meta-Analysis

Hiroyuki Takamaru Jaeyoung Chun Jihye Kim Jooyoung Lee Hyun Jung Lee Hyunsoo Chung Soo-Jeong Cho Jong Pil Im Sang Gyun Kim Joo Sung Kim 2020년

논문상세정보
인용/피인용
' Efficacy and Safety of Ghrelin Agonists in Patients with Diabetic Gastroparesis: A Systematic Review and Meta-Analysis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Diabetes mellitus
  • Ghrelin
  • Systematic review
  • gastroparesis
  • meta analysis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
2,220 0

0.0%

' Efficacy and Safety of Ghrelin Agonists in Patients with Diabetic Gastroparesis: A Systematic Review and Meta-Analysis' 의 참고문헌

  • Visceral hypersensitivity and impaired accommodation in refractory diabetic gastroparesis
    Kumar A [2008]
  • The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis
    Janssen P [2013]
  • The investigation and treatment of diabetic gastroparesis
    Kumar M [2018]
  • The ghrelin agonist RM-131accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus
    Shin A [2013]
  • The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions:explanation and elaboration
    Liberati A [2009]
  • The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
    Higgins JP [2011]
  • Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis : a randomized, placebo-controlled study
    Ejskjaer N [2010]
  • Risk of gastroparesis in subjects with type 1and 2 diabetes in the general population
    Choung RS [2012]
  • Relamorelin reduces vomiting frequency and severity and accelerates gastric emptying in adults with diabetic gastroparesis
    Lembo A [2016]
  • Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying : pharmacokinetics and pharmacodynamics
    Shin A [2013]
  • Randomised clinical trial : ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting--randomised clinical study subset data
    Wo JM [2011]
  • Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131
  • Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis
    McCallum RW [2013]
  • Pharmacological demarcation of the growth hormone, gut motility and feeding effects of ghrelin using a novel ghrelin receptor agonist
    Fraser GL [2008]
  • Pathophysiology and treatment of functional dyspepsia
    Tack J [2004]
  • Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review
    Sever S [2016]
  • Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man
    Ang D [2009]
  • Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin
    Dass NB [2003]
  • Ghrelin signaling in the gut, its physiological properties, and therapeutic potential
    Avau B [2013]
  • Ghrelin receptor agonist(TZP-101)accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis
    Ejskjaer N [2009]
  • Ghrelin enhances gastric emptying in diabetic gastroparesis : a double blind, placebo controlled, crossover study
    Murray CD [2005]
  • Ghrelin agonist(TZP-101) : safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers : a phase I, first-in-human study
    Lasseter KC [2008]
  • Gastroparesis Updates on Pathogenesis and Management
    Nanlong Liu [2017]
  • Gastroparesis Cardinal Symptom Index(GCSI) : development and validation of a patient reported assessment of severity of gastroparesis symptoms
    Revicki DA [2004]
  • Gastroduodenal motility disorders
    Tack J [2018]
  • Functional dyspepsia
    Enck P [2017]
  • Evidence for the presence of motilin, ghrelin, and the motilin and ghrelin receptor in neurons of the myenteric plexus
    Xu L [2005]
  • Evaluating symptom outcomes in gastroparesis clinical trials : validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary(GCSI-DD)
    Revicki DA [2012]
  • Epidemiology, mechanisms, and management of diabetic gastroparesis
    Camilleri M [2011]
  • Efficacy and safety of relamorelin in diabetics with symptoms of gastroparesis : a randomized, placebo-controlled study
    Camilleri M [2017]
  • Development and psychometric evaluation of the Patient Assessment of Upper Gastrointestinal Symptom Severity Index(PAGI-SYM)in patients with upper gastrointestinal disorders
    Rentz AM [2004]
  • Cancer risks in patients treated with growth hormone in childhood : the SAGhE European Cohort Study
    Swerdlow AJ [2017]
  • Bloating and functional gastro-intestinal disorders : where are we and where are we going
    Iovino P [2014]
  • Assessment of symptoms during gastric emptying scintigraphy to correlate symptoms to delayed gastric emptying
    Khayyam U [2010]
  • Antinociceptive effect of ghrelin in a rat model of irritable bowel syndrome involves TRPV1/Opioid systems
    Mao Y [2017]
  • American College of Gastroenterology
    Camilleri M [2013]
  • Actions and therapeutic pathways of ghrelin for gastrointestinal disorders
    Camilleri M [2009]
  • A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis
    Ejskjaer N [2013]